Literature DB >> 18356040

The reprogramming language of pluripotency.

G Grant Welstead1, Patrick Schorderet, Laurie A Boyer.   

Abstract

In metazoans, lineage-specific transcription factors and epigenetic modifiers function to establish and maintain proper gene expression programs during development. Recent landmark studies in both mouse and human have defined a set of transcription factors whose ectopic expression by retroviral transduction is capable of reprogramming a somatic nucleus to the pluripotent state. The identification of factors that are sufficient for the induction of pluripotency suggests that rewiring transcriptional regulatory networks at the molecular level can be used to manipulate cell fate in vitro. These findings have broad implications for understanding development and disease and for the potential use of stem cells in therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356040     DOI: 10.1016/j.gde.2008.01.013

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  12 in total

Review 1.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 2.  Epigenetic regulation in African trypanosomes: a new kid on the block.

Authors:  Luisa M Figueiredo; George A M Cross; Christian J Janzen
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

3.  Genes for embryo development are packaged in blocks of multivalent chromatin in zebrafish sperm.

Authors:  Shan-Fu Wu; Haiying Zhang; Bradley R Cairns
Journal:  Genome Res       Date:  2011-03-07       Impact factor: 9.043

4.  Development and gene expression of porcine cloned embryos derived from bone marrow stem cells with overexpressing Oct4 and Sox2.

Authors:  Jeong-Hyeon Lee; Won-Jae Lee; Ryoung-Hoon Jeon; Yeon-Mi Lee; Si-Jung Jang; Sung-Lim Lee; Byung-Geun Jeon; Sun-A Ock; W Allen King; Gyu-Jin Rho
Journal:  Cell Reprogram       Date:  2014-12       Impact factor: 1.987

5.  Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation.

Authors:  Daan Peric-Hupkes; Wouter Meuleman; Ludo Pagie; Sophia W M Bruggeman; Irina Solovei; Wim Brugman; Stefan Gräf; Paul Flicek; Ron M Kerkhoven; Maarten van Lohuizen; Marcel Reinders; Lodewyk Wessels; Bas van Steensel
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

6.  N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor.

Authors:  Rebecca Cotterman; Victor X Jin; Sheryl R Krig; Jessica M Lemen; Alice Wey; Peggy J Farnham; Paul S Knoepfler
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

7.  The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming.

Authors:  Ilaria Marzi; Maria Grazia Cipolleschi; Massimo D'Amico; Theodora Stivarou; Elisabetta Rovida; Maria Cristina Vinci; Silvia Pandolfi; Persio Dello Sbarba; Barbara Stecca; Massimo Olivotto
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

8.  Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.

Authors:  Agamemnon E Grigoriadis; Marion Kennedy; Aline Bozec; Fiona Brunton; Gudrun Stenbeck; In-Hyun Park; Erwin F Wagner; Gordon M Keller
Journal:  Blood       Date:  2010-01-11       Impact factor: 22.113

Review 9.  The molecular mechanism of induced pluripotency: a two-stage switch.

Authors:  Wouter Scheper; Sjef Copray
Journal:  Stem Cell Rev Rep       Date:  2009-06-24       Impact factor: 5.739

10.  Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels.

Authors:  Andriana Margariti; Bernhard Winkler; Eirini Karamariti; Anna Zampetaki; Tsung-neng Tsai; Dilair Baban; Jiannis Ragoussis; Yi Huang; Jing-Dong J Han; Lingfang Zeng; Yanhua Hu; Qingbo Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.